Impacts of Community Pediatric Asthma Education Program on Asthma Outcomes in Alberta, Canada

加拿大阿尔伯塔省社区儿科哮喘教育项目对哮喘治疗效果的影响

阅读:1

Abstract

OBJECTIVE: Asthma affects about 10% of Canadian children, with significant impacts on the healthcare system. This study describes a cohort of children with asthma, exploring outcomes of targeted asthma education through a Community Pediatric Asthma Service (CPAS). METHODS: This retrospective cohort of children aged 1-17 years in Calgary, Alberta with asthma compares those who received CPAS 2016-2019 to the entire cohort. For CPAS recipients, rates of severe asthma exacerbations were evaluated biannually from 12 months before to 24 months after CPAS. RESULTS: Of 60,555 children with asthma, 3589 attended CPAS. Compared to the 56,966 controls, CPAS attendees were more likely to be male (60.2% vs. 58.4%), approximately 2 years younger at asthma diagnosis, and demonstrate poor asthma control (32.7% vs. 19.1% ED visits in the year following diagnosis). The incidence risk ratio (IRR) for asthma exacerbations for 2 years following CPAS was 0.85 (95% CI: 0.80-0.90). There was a reduction in ED visits (IRR: 0.82; 95% CI: 0.76-0.90) and oral steroid use (IRR: 0.86; 95% CI: 0.80-0.93). CPAS was not associated with reduced hospitalizations for asthma (IRR: 0.91; 95% CI: 0.68-1.22). A subset analysis demonstrated an 18-month decrease in severe exacerbations for CPAS recipients (985) compared to propensity-matched controls (985) that reached significance at 12-18 months with extinction of the positive CPAS effect by 2 years. CONCLUSION: A targeted community asthma education service decreased severe exacerbations, with effect retention for at least 18 months. Educating children and their caretakers on asthma management thus provides an opportunity to improve pediatric lung health and should be considered for children at risk of asthma exacerbations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。